Does Timing Matter In Hormone Therapy? Study highlights: Women who began hormone therapy soon after menopause did not show reduced blood vessel function raising the question of whether the negative effects of hormone therapy in recent trials might be avoided in younger patients. Results of ongoing rigorous, randomized and controlled studies of younger menopausal women on hormone therapy are needed before considering changes to current guidelines.
Source: www.medicalnewstoday.comGAVI Response To Tracking Progress In Maternal, Newborn & Child Survival, The 2008 Report Statement by Julian Lob-Levyt, GAVI Alliance Executive SecretaryThe 2008 report issued in Cape Town provides a significant assessment of the progress in maternal, newborn and child survival. I am pleased to see the report's particular focus on the pivotal role of immunisation in efforts to reach the Millennium Development Goals (MDGs), especially MDG 4, which aims at reducing by two thirds the mortality rate among children under five.
Source: www.medicalnewstoday.comJournal Of Women's Health Named Official Journal Of American Medical Women's Association The American Medical Women's Association (AMWA), an organization devoted to the advancement of women in
medicine and the improvement of women's
health, has named Journal of Women's
Health as its official journal.
Source: www.medicalnewstoday.comPainless Hemorrhoid Treatment Featured In Leading Physicians' Magazine The Ultroid Hemorrhoid Treatment, which provides an innovative and non-surgical approach to treating hemorrhoids, was recently featured in Physicians Office Resource. The trade magazine features products and editorials directly targeted to individuals in the medical profession.
Source: www.medicalnewstoday.comOral Drug For Pain From Cone Snails And Plants Molecules from cone snail venom and African plants are being used by Queensland researchers as a blueprint to develop an oral drug to treat chronic pain.Professor David Craik and Dr Richard Clark from the Institute for Molecular Bioscience have received $218,275 from the National
Health and Medical Research Council (NHMRC) to aid in translating their research into a product available for Australians to use.
Source: www.medicalnewstoday.comOral Prolonged Release Oxycodone / Naloxone Combination Reduces Opioid-induced Constipation In Severe Chronic Pain Patients, With No Loss Of Analgesia The addition of oral prolonged release (PR) naloxone, an opioid antagonist, to the opioid PR oxycodone significantly reduces opioid-induced constipation (OIC) in severe chronic pain patients without affecting analgesia, according to three new studies presented at this year's British Pain Society Annual Scientific Meeting in Liverpool.
Source: www.medicalnewstoday.comSchering-Plough Announces Imperfect Contraceptive Use Impacts Women's Emotional Well-Being Schering-Plough Corporation announced results of a recently completed study showing that non-compliance with combined hormonal contraceptives has noticeable effects on women's emotional well-being, prompted requests for physicians' advice and led to increased use of emergency contraception. Results were presented in Madrid, Spain, and were published earlier this month in Contraception.
Source: www.medicalnewstoday.comHouse Subcommittee Approves Amended Parental Leave Bill For Federal Employees The House Oversight and Government Reform Committee's Federal Workforce Subcommittee on Tuesday approved an amended version of a bill (
Source: www.medicalnewstoday.comGetting A Good Night's Sleep Is The Biggest Problem For Women Entering The Menopause Sleep disruption is the most common and severe symptom reported by middle-aged women when their periods change and they start moving into the menopause,according to a study in the April issue of the UK-based Journal of Clinical Nursing. Researchers at the University of Arizona College of Nursing, USA, spoke to 110 women entering the menopause - when periods can become lighter or heavier and occur at longer or shorter intervals.
Source: www.medicalnewstoday.com
# posted by Network @ 11:00 AM
